Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

Can prostate cancer be NICE?

Richenberg J.

Clin Radiol. 2019 Jul 16. pii: S0009-9260(19)30299-5. doi: 10.1016/j.crad.2019.06.009. [Epub ahead of print] Review.

PMID:
31324338
2.

Interim Process and Methods Guide for the Clinical Guideline Updates Using Standing Committees Pilot Programme 2013 [Internet].

National Institute for Health and Care Excellence.

London: National Institute for Health and Care Excellence (NICE); 2013 Oct 14.

3.
4.

Evidence Summaries: Unlicensed and Off-Label Medicines – Integrated Process Statement [Internet].

National Institute for Health and Care Excellence.

London: National Institute for Health and Care Excellence (NICE); 2013 May 7.

5.

[Procedures and methods of benefit assessments for medicines in Germany].

Bekkering GE, Kleijnen J.

Dtsch Med Wochenschr. 2008 Dec;133 Suppl 7:S225-46. doi: 10.1055/s-0028-1100954. Epub 2008 Nov 25. German.

PMID:
19034813
6.

Procedures and methods of benefit assessments for medicines in Germany.

Bekkering GE, Kleijnen J.

Eur J Health Econ. 2008 Nov;9 Suppl 1:5-29. doi: 10.1007/s10198-008-0122-5.

PMID:
18987905
7.

General application of the National Institute for Health and Clinical Excellence (NICE) guidance for active surveillance for men with prostate cancer is not appropriate in unscreened populations.

Wong LM, Johnston R, Sharma N, Shah NC, Warren AY, Neal DE.

BJU Int. 2012 Jul;110(1):24-7. doi: 10.1111/j.1464-410X.2011.10730.x. Epub 2011 Nov 11.

8.

Informing a decision framework for when NICE should recommend the use of health technologies only in the context of an appropriately designed programme of evidence development.

Claxton K, Palmer S, Longworth L, Bojke L, Griffin S, McKenna C, Soares M, Spackman E, Youn J.

Health Technol Assess. 2012;16(46):1-323. doi: 10.3310/hta16460.

9.

What is the value of routinely testing full blood count, electrolytes and urea, and pulmonary function tests before elective surgery in patients with no apparent clinical indication and in subgroups of patients with common comorbidities: a systematic review of the clinical and cost-effective literature.

Czoski-Murray C, Lloyd Jones M, McCabe C, Claxton K, Oluboyede Y, Roberts J, Nicholl JP, Rees A, Reilly CS, Young D, Fleming T.

Health Technol Assess. 2012 Dec;16(50):i-xvi, 1-159. doi: 10.3310/hta16500. Review.

10.

Economic modelling of diagnostic and treatment pathways in National Institute for Health and Care Excellence clinical guidelines: the Modelling Algorithm Pathways in Guidelines (MAPGuide) project.

Lord J, Willis S, Eatock J, Tappenden P, Trapero-Bertran M, Miners A, Crossan C, Westby M, Anagnostou A, Taylor S, Mavranezouli I, Wonderling D, Alderson P, Ruiz F.

Health Technol Assess. 2013 Dec;17(58):v-vi, 1-192. doi: 10.3310/hta17580.

11.

Methods for the Development of NICE Public Health Guidance [Internet].

National Institute for Health and Care Excellence.

London: National Institute for Health and Care Excellence (NICE); 2012 Sep 26.

12.

Nasty or Nice? Findings from a UK Survey to evaluate the impact of the National Institute for Health and Clinical Excellence (NICE) clinical guidelines on the management of prostate cancer.

Payne H, Clarke N, Huddart R, Parker C, Troup J, Graham J.

Clin Oncol (R Coll Radiol). 2013 Mar;25(3):178-89. doi: 10.1016/j.clon.2012.09.001. Epub 2012 Oct 15.

PMID:
23079099
13.

Microbiological aspects of the UK National Institute for Health and Clinical Excellence (NICE) guidance on urinary tract infection in children.

Price E, Pallett A, Gilbert RD, Williams C.

J Antimicrob Chemother. 2010 May;65(5):836-41. doi: 10.1093/jac/dkq045. Epub 2010 Mar 4. Review.

PMID:
20202989
14.

Conscious sedation guidance.

Coulthard P.

Evid Based Dent. 2006;7(4):90-1.

PMID:
17187034
15.

Economic evaluation and decision making in the UK.

Buxton MJ.

Pharmacoeconomics. 2006;24(11):1133-42. Review.

PMID:
17067197
16.
17.

NICE public health guidance update.

McGuire H, Desai M, Leng G, Richardson J.

J Public Health (Oxf). 2018 Dec 1;40(4):900-902. doi: 10.1093/pubmed/fdy132.

PMID:
30113696
18.

The Social Care Guidance Manual [Internet].

National Institute for Health and Care Excellence.

London: National Institute for Health and Care Excellence (NICE); 2016 Jul 7.

19.

NICE public health guidance update.

Van Hove M, Kettle R, Walsh R, Leng G.

J Public Health (Oxf). 2018 Oct 31. doi: 10.1093/pubmed/fdy195. [Epub ahead of print]

PMID:
30380066
20.

Cabazitaxel for Hormone-Relapsed Metastatic Prostate Cancer Previously Treated With a Docetaxel-Containing Regimen: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.

Kearns B, Pandor A, Stevenson M, Hamilton J, Chambers D, Clowes M, Graham J, Kumar MS.

Pharmacoeconomics. 2017 Apr;35(4):415-424. doi: 10.1007/s40273-016-0457-1. Review.

Supplemental Content

Support Center